Uterine fibroids, scientifically known as leiomyomas or myomas, are benign monoclonal tumors originating from the smooth muscle cells of the myometrium, interspersed with an extracellular matrix rich in collagen. While exceedingly common in women of reproductive age—with a particularly high prevalence and early onset among women of African descent—they frequently remain asymptomatic. Anatomically, fibroids are classified by their precise location within the uterine walls:
The exact initiating event for leiomyoma formation remains under active investigation, but current evidence confirms they are monoclonal tumors, meaning each individual fibroid arises from a single mutated myometrial cell. Hormonal dependence is a hallmark feature: both estrogen and progesterone stimulate tumor growth, which explains why fibroids enlarge during reproductive years and typically regress following menopause. Estrogen upregulates receptors and promotes cell proliferation, while progesterone acts synergistically, maintaining mitosis in the luteal phase of the menstrual cycle. Genetic predispositions, local growth factors like transforming growth factor-beta (TGF-beta), and altered extracellular matrix metabolism further drive cellular expansion and localized ischemia.
Many women harbor fibroids without experiencing any noticeable symptoms, discovering them incidentally during routine pelvic examinations or obstetric ultrasound scans. When symptoms do manifest, they vary widely depending on the size, number, and exact anatomical location of the tumors.
Common clinical features include heavy menstrual bleeding (menorrhagia), which can lead to iron deficiency anemia, and prolonged menses. Bulk-related symptoms occur as large masses press against neighboring pelvic organs, resulting in urinary frequency, constipation, or a persistent sensation of pelvic heaviness. Dysmenorrhea and dyspareunia are also frequently reported. Acute pain can develop during episodes of red degeneration—a form of ischemic infarction that occurs when a rapidly growing fibroid outgrows its blood supply, typically during pregnancy.
Diagnosing uterine fibroids begins with a thorough clinical history and a bimanual pelvic examination, which often reveals an enlarged, irregularly contoured, or firm uterus. Confirming the diagnosis and mapping the precise number and location of the tumors, however, relies primarily on imaging studies.
Pelvic ultrasonography—both transabdominal and transvaginal—is the standard first-line imaging modality due to its wide availability, safety, and high accuracy for identifying myomas. When complex surgical planning is required or when ultrasound findings are inconclusive, magnetic resonance imaging (MRI) offers superior visualization of exact tissue planes and vascular supply. Hysteroscopy provides direct endoscopic visualization of the uterine cavity, making it the gold standard for diagnosing and treating submucosal fibroids.
Management of uterine fibroids is highly individualized, depending on symptom severity, the patient's age, overall health, and future fertility desires. Asymptomatic fibroids generally require no intervention beyond regular clinical monitoring.
Medical therapy aims to control bleeding and reduce tumor bulk. Options include non-steroidal anti-inflammatory drugs (NSAIDs), tranexamic acid, combined oral contraceptives, and gonadotropin-releasing hormone (GnRH) agonists or antagonists, which induce a temporary hypoestrogenic state to shrink tumors prior to surgery.
Surgical interventions range from uterus-preserving procedures to definitive treatment:
Comprehensive nursing care for patients with uterine fibroids addresses both physical symptoms and psychological well-being. Midwives and nurses must assess the impact of menorrhagia on hemoglobin levels, screening for signs of iron deficiency anemia such as fatigue, pallor, and dizziness. Administering prescribed iron supplements and educating patients on iron-rich dietary intake are essential daily tasks.
Pain management requires monitoring responses to analgesics and providing comfort measures such as warm pelvic packs. Pre- and postoperative care involves thorough surgical preparation, monitoring for post-procedural hemorrhage, and encouraging early ambulation to prevent venous thromboembolism. Because fibroids can threaten a woman's sense of bodily integrity or fertility, providing empathetic counseling and space for emotional expression is a vital component of holistic care.